rs122445111
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000373344.11(ATRX):c.659G>A(p.Cys220Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C220R) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000373344.11 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATRX | NM_000489.6 | c.659G>A | p.Cys220Tyr | missense_variant | 8/35 | ENST00000373344.11 | NP_000480.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATRX | ENST00000373344.11 | c.659G>A | p.Cys220Tyr | missense_variant | 8/35 | 1 | NM_000489.6 | ENSP00000362441 | P3 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome Cov.: 27
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2016 | - - |
Alpha thalassemia-X-linked intellectual disability syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 10, 2021 | Variant summary: ATRX c.659G>A (p.Cys220Tyr) results in a non-conservative amino acid change located in the ADD domain (IPR025766) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183067 control chromosomes (gnomAD). c.659G>A has been reported in the literature co-segregating with disease in a family with multiple individuals affected with ATR-X Syndrome (Stevenson_2000). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A ClinVar submitter (evaluation after 2014) cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Intellectual disability-hypotonic facies syndrome, X-linked Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Oct 23, 2000 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at